Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for ERHÖHUNG DER BIOVERFÜGBARKEIT VON HEILMITTELN IN EINER NALTREXONTHERAPIE
Details for 2011845186
Up to date per 11.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2011845186
Title / Product Name
ERHÖHUNG DER BIOVERFÜGBARKEIT VON HEILMITTELN IN EINER NALTREXONTHERAPIE
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2011845186
EP Publication Number
2646031
E-Number
868738
Language
EN
PCT Number
US11063177
Publication Date
09.10.2013 A
22.02.2017 B1
Registration Date
22.02.2017
AT Publication Date
15.03.2017
Application Date
02.12.2011
Registration Number
-
Priorities
03.12.2010
US
419395 P
IPC
A61K 31/485 20060101AFI20140318BHEP
Maximum Duration of Protection
02.12.2031
Owner
Orexigen Therapeutics, Inc.
3344 North Torrey Pines Court, Suite 200
La Jolla, CA 92037
US
Representative
Representative
Häupl & Ellmeyer KG Patentanwaltskanzlei
Mariahilfer Straße 50 (Eingang Kirchengasse 1)
1070 Wien
AT
Inventor
FLANAGAN, Shawn
14083 Via Corsini
San Diego CA 92128
US
DUNAYEVICH, Eduardo
1030 Deep Wood Drive
Westlake Village, CA 91362
US